Marty Hinz, MD Retraction Bibliography

To access these papers go to www.dovepress.com then search the title of the paper or authors.

1. Trachte, G. Uncini, T. Hinz, M, Both stimulatory and inhibitory effects of dietary 5‐ hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population Neuropsychiatric Disease and Treatment, 2009, 5:227–2358.
2. Hinz, M. Stein, A, Uncini T. The dual‐gate lumen model of renal monoamine transport Neuropsychiatric Disease and Treatment, 2010, 6 387–392
3. Hinz, M. Stein, A, Trachte, G, Uncini T. Neurotransmitter testing of the urine; a comprehensive analysis. Open Access Journal of Urology 2010:2 177–183
4. Hinz, M. Stein, A. Uncini T. A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole, NeuroPsychiatric Disease and Treatment Neuropsychiatric Disease and Treatment: 2010, 6:741–747
5. Stein, A. Hinz, M. Uncini T. Amino acid responsive Crohn’s disease, a case study. Clinical and Experimental Gastroenterology 2010:3 171–177
6. Hinz, M. Stein A. Uncini T. Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation Neuropsychiatric Disease and Treatment 2011:7 31–38
7. Hinz, M. Stein, A. Uncini T. Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine Open Access Journal of Urology 2011:3 19–24
8. Hinz, M. Stein, A. Uncini T. Amino acid management of Parkinson disease: A case study International Journal of General Medicine 2011:4 1–10
9. Hinz, M. Stein, A. Uncini T. Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model” International Journal of Nephrology and Renovascular Disease 2011:4 101–113
10. Stein, A. McAleer, S. Hinz, M. Microperforation prolotherapy: a novel method for successful nonsurgical treatment of atraumatic spontaneous anterior sternoclavicular subluxation, with an illustrative case, Open Access Journal of Sports Medicine 2011:2 47–52
11. Hinz, M. Stein, A. Uncini T. APRESS: apical regulatory super system, serotonin, and dopamine interaction Neuropsychiatric Disease and Treatment 2011 2011:7 1–7
12. Hinz, M. Stein, A. Uncini T. Monoamine depletion by reuptake inhibitors International Drug, Healthcare and Patient Safety 2011:3 69–77
13. Hinz, M. Stein, A. Uncini T. The discrediting of the monoamine hypothesis International Journal of General Medicine 2012:5 135–142
14. Hinz, M. Stein, A. Uncini T. Relative nutritional deficiencies associated with centrally acting monoamines. International Journal of General Medicine International Journal of General Medicine 2012:5 413–430, 412‐431
15. Hinz, M. Stein, A. Uncini T. 5‐HTP efficacy and contraindications. International Journal of General Medicine 2012:5 413–430
16. Hinz, M. et. al. Administration of Supplemental L‐tyrosine with Phenelzine: A Clinical Literature Review. Clinical Pharmacology: Advances and Applications 2014:6 107–110 22 July 2014
17. Hinz, M. et. al. Management of L‐dopa overdose in the competitive inhibition state Drug, Healthcare and Patient Safety 2014:6 93–99 22 July 2014
18. Hinz M. et. al. The Parkinson’s disease death rate: carbidopa and vitamin B6 Clinical Pharmacology: Advances and Applications 2014:6 161–169 21 October 2014
19. Hinz, M. et. al. Parkinson’s disease: carbidopa, nausea, and dyskinesia Clinical Pharmacology: Advances and Applications 2014:6 189–194 14 November 2014
20. Hinz, M. et. al. Parkinson’s disease‐associated melanin steal Neuropsychiatric Disease and Treatment 2014:10 2331–2337 10 December 2014
21. Hinz, M. et. al. Parkinson’s disease managing reversible neurodegeneration Neuropsychiatric Disease and Treatment 2016:12 763–775 5 April, 2016